Cell Discovery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2181467, encodeId=1748218146ef0, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jan 13 22:26:53 CST 2024, time=2024-01-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2134511, encodeId=5b3d2134511d4, content=Manuscript Under Consideration已经两个月了，请问是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3475520673, createdName=ms5000000882465531, createdTime=Mon May 15 15:30:16 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169851, encodeId=0b3321698518a, content=偏重的研究方向：信号通路;干细胞;GPCR 经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0838839473, createdName=ms2000001058758215, createdTime=Mon Nov 20 23:27:44 CST 2023, time=2023-11-20, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2141041, encodeId=5ca4214104108, content=Cell Discovery能比得上Mol Cell不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Tue Jun 06 10:38:36 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189973, encodeId=234021899e304, content=偏重的研究方向：免疫、单细胞测序 经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ce55107049, createdName=146080dfm79(暂无昵称), createdTime=Wed Feb 28 21:26:55 CST 2024, time=2024-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180511, encodeId=72062180511bb, content=请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d96302450, createdName=3783633_3040, createdTime=Wed Jan 10 15:23:06 CST 2024, time=2024-01-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170492, encodeId=db6921e0492ae, content=杂志口碑一般，有好的科研成果建议投其他子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8a8233627, createdName=ms8000001941475625, createdTime=Thu Nov 23 11:49:13 CST 2023, time=2023-11-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570206, encodeId=160c5e0206ee, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a32141202, createdName=05482, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576357, encodeId=3f5f5e6357e0, content=今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2311682109, createdName=加州理工的工人, createdTime=Sun Sep 15 19:42:00 CST 2019, time=2019-09-15, status=1, ipAttribution=)]

2024-01-13 dgdgdgygygyg 来自上海

审稿速度:2.0 | 投稿命中率:25.0
经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。

146 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181467, encodeId=1748218146ef0, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jan 13 22:26:53 CST 2024, time=2024-01-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2134511, encodeId=5b3d2134511d4, content=Manuscript Under Consideration已经两个月了，请问是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3475520673, createdName=ms5000000882465531, createdTime=Mon May 15 15:30:16 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169851, encodeId=0b3321698518a, content=偏重的研究方向：信号通路;干细胞;GPCR 经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0838839473, createdName=ms2000001058758215, createdTime=Mon Nov 20 23:27:44 CST 2023, time=2023-11-20, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2141041, encodeId=5ca4214104108, content=Cell Discovery能比得上Mol Cell不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Tue Jun 06 10:38:36 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189973, encodeId=234021899e304, content=偏重的研究方向：免疫、单细胞测序 经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ce55107049, createdName=146080dfm79(暂无昵称), createdTime=Wed Feb 28 21:26:55 CST 2024, time=2024-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180511, encodeId=72062180511bb, content=请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d96302450, createdName=3783633_3040, createdTime=Wed Jan 10 15:23:06 CST 2024, time=2024-01-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170492, encodeId=db6921e0492ae, content=杂志口碑一般，有好的科研成果建议投其他子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8a8233627, createdName=ms8000001941475625, createdTime=Thu Nov 23 11:49:13 CST 2023, time=2023-11-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570206, encodeId=160c5e0206ee, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a32141202, createdName=05482, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576357, encodeId=3f5f5e6357e0, content=今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2311682109, createdName=加州理工的工人, createdTime=Sun Sep 15 19:42:00 CST 2019, time=2019-09-15, status=1, ipAttribution=)]

2023-05-15 ms5000000882465531 来自广东省

Manuscript Under Consideration已经两个月了，请问是送审了吗？

153 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181467, encodeId=1748218146ef0, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jan 13 22:26:53 CST 2024, time=2024-01-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2134511, encodeId=5b3d2134511d4, content=Manuscript Under Consideration已经两个月了，请问是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3475520673, createdName=ms5000000882465531, createdTime=Mon May 15 15:30:16 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169851, encodeId=0b3321698518a, content=偏重的研究方向：信号通路;干细胞;GPCR 经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0838839473, createdName=ms2000001058758215, createdTime=Mon Nov 20 23:27:44 CST 2023, time=2023-11-20, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2141041, encodeId=5ca4214104108, content=Cell Discovery能比得上Mol Cell不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Tue Jun 06 10:38:36 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189973, encodeId=234021899e304, content=偏重的研究方向：免疫、单细胞测序 经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ce55107049, createdName=146080dfm79(暂无昵称), createdTime=Wed Feb 28 21:26:55 CST 2024, time=2024-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180511, encodeId=72062180511bb, content=请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d96302450, createdName=3783633_3040, createdTime=Wed Jan 10 15:23:06 CST 2024, time=2024-01-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170492, encodeId=db6921e0492ae, content=杂志口碑一般，有好的科研成果建议投其他子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8a8233627, createdName=ms8000001941475625, createdTime=Thu Nov 23 11:49:13 CST 2023, time=2023-11-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570206, encodeId=160c5e0206ee, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a32141202, createdName=05482, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576357, encodeId=3f5f5e6357e0, content=今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2311682109, createdName=加州理工的工人, createdTime=Sun Sep 15 19:42:00 CST 2019, time=2019-09-15, status=1, ipAttribution=)]

2023-11-20 ms2000001058758215 来自德国

偏重的研究方向：信号通路;干细胞;GPCR
经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。

147 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181467, encodeId=1748218146ef0, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jan 13 22:26:53 CST 2024, time=2024-01-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2134511, encodeId=5b3d2134511d4, content=Manuscript Under Consideration已经两个月了，请问是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3475520673, createdName=ms5000000882465531, createdTime=Mon May 15 15:30:16 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169851, encodeId=0b3321698518a, content=偏重的研究方向：信号通路;干细胞;GPCR 经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0838839473, createdName=ms2000001058758215, createdTime=Mon Nov 20 23:27:44 CST 2023, time=2023-11-20, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2141041, encodeId=5ca4214104108, content=Cell Discovery能比得上Mol Cell不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Tue Jun 06 10:38:36 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189973, encodeId=234021899e304, content=偏重的研究方向：免疫、单细胞测序 经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ce55107049, createdName=146080dfm79(暂无昵称), createdTime=Wed Feb 28 21:26:55 CST 2024, time=2024-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180511, encodeId=72062180511bb, content=请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d96302450, createdName=3783633_3040, createdTime=Wed Jan 10 15:23:06 CST 2024, time=2024-01-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170492, encodeId=db6921e0492ae, content=杂志口碑一般，有好的科研成果建议投其他子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8a8233627, createdName=ms8000001941475625, createdTime=Thu Nov 23 11:49:13 CST 2023, time=2023-11-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570206, encodeId=160c5e0206ee, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a32141202, createdName=05482, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576357, encodeId=3f5f5e6357e0, content=今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2311682109, createdName=加州理工的工人, createdTime=Sun Sep 15 19:42:00 CST 2019, time=2019-09-15, status=1, ipAttribution=)]

2023-06-06 尊严

Cell Discovery能比得上Mol Cell不？

164 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181467, encodeId=1748218146ef0, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jan 13 22:26:53 CST 2024, time=2024-01-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2134511, encodeId=5b3d2134511d4, content=Manuscript Under Consideration已经两个月了，请问是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3475520673, createdName=ms5000000882465531, createdTime=Mon May 15 15:30:16 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169851, encodeId=0b3321698518a, content=偏重的研究方向：信号通路;干细胞;GPCR 经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0838839473, createdName=ms2000001058758215, createdTime=Mon Nov 20 23:27:44 CST 2023, time=2023-11-20, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2141041, encodeId=5ca4214104108, content=Cell Discovery能比得上Mol Cell不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Tue Jun 06 10:38:36 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189973, encodeId=234021899e304, content=偏重的研究方向：免疫、单细胞测序 经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ce55107049, createdName=146080dfm79(暂无昵称), createdTime=Wed Feb 28 21:26:55 CST 2024, time=2024-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180511, encodeId=72062180511bb, content=请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d96302450, createdName=3783633_3040, createdTime=Wed Jan 10 15:23:06 CST 2024, time=2024-01-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170492, encodeId=db6921e0492ae, content=杂志口碑一般，有好的科研成果建议投其他子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8a8233627, createdName=ms8000001941475625, createdTime=Thu Nov 23 11:49:13 CST 2023, time=2023-11-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570206, encodeId=160c5e0206ee, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a32141202, createdName=05482, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576357, encodeId=3f5f5e6357e0, content=今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2311682109, createdName=加州理工的工人, createdTime=Sun Sep 15 19:42:00 CST 2019, time=2019-09-15, status=1, ipAttribution=)]

2024-02-28 146080dfm79(暂无昵称) 来自北京

偏重的研究方向：免疫、单细胞测序
经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑...

143 0

[GetPortalCommentsPageByObjectIdResponse(id=2181467, encodeId=1748218146ef0, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jan 13 22:26:53 CST 2024, time=2024-01-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2134511, encodeId=5b3d2134511d4, content=Manuscript Under Consideration已经两个月了，请问是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3475520673, createdName=ms5000000882465531, createdTime=Mon May 15 15:30:16 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169851, encodeId=0b3321698518a, content=偏重的研究方向：信号通路;干细胞;GPCR 经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0838839473, createdName=ms2000001058758215, createdTime=Mon Nov 20 23:27:44 CST 2023, time=2023-11-20, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2141041, encodeId=5ca4214104108, content=Cell Discovery能比得上Mol Cell不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Tue Jun 06 10:38:36 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189973, encodeId=234021899e304, content=偏重的研究方向：免疫、单细胞测序 经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ce55107049, createdName=146080dfm79(暂无昵称), createdTime=Wed Feb 28 21:26:55 CST 2024, time=2024-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180511, encodeId=72062180511bb, content=请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d96302450, createdName=3783633_3040, createdTime=Wed Jan 10 15:23:06 CST 2024, time=2024-01-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170492, encodeId=db6921e0492ae, content=杂志口碑一般，有好的科研成果建议投其他子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8a8233627, createdName=ms8000001941475625, createdTime=Thu Nov 23 11:49:13 CST 2023, time=2023-11-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570206, encodeId=160c5e0206ee, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a32141202, createdName=05482, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576357, encodeId=3f5f5e6357e0, content=今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2311682109, createdName=加州理工的工人, createdTime=Sun Sep 15 19:42:00 CST 2019, time=2019-09-15, status=1, ipAttribution=)]

2024-01-10 3783633_3040 来自安徽省

请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？

97 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181467, encodeId=1748218146ef0, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jan 13 22:26:53 CST 2024, time=2024-01-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2134511, encodeId=5b3d2134511d4, content=Manuscript Under Consideration已经两个月了，请问是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3475520673, createdName=ms5000000882465531, createdTime=Mon May 15 15:30:16 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169851, encodeId=0b3321698518a, content=偏重的研究方向：信号通路;干细胞;GPCR 经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0838839473, createdName=ms2000001058758215, createdTime=Mon Nov 20 23:27:44 CST 2023, time=2023-11-20, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2141041, encodeId=5ca4214104108, content=Cell Discovery能比得上Mol Cell不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Tue Jun 06 10:38:36 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189973, encodeId=234021899e304, content=偏重的研究方向：免疫、单细胞测序 经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ce55107049, createdName=146080dfm79(暂无昵称), createdTime=Wed Feb 28 21:26:55 CST 2024, time=2024-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180511, encodeId=72062180511bb, content=请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d96302450, createdName=3783633_3040, createdTime=Wed Jan 10 15:23:06 CST 2024, time=2024-01-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170492, encodeId=db6921e0492ae, content=杂志口碑一般，有好的科研成果建议投其他子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8a8233627, createdName=ms8000001941475625, createdTime=Thu Nov 23 11:49:13 CST 2023, time=2023-11-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570206, encodeId=160c5e0206ee, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a32141202, createdName=05482, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576357, encodeId=3f5f5e6357e0, content=今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2311682109, createdName=加州理工的工人, createdTime=Sun Sep 15 19:42:00 CST 2019, time=2019-09-15, status=1, ipAttribution=)]

2023-11-23 ms8000001941475625 来自江苏省

杂志口碑一般，有好的科研成果建议投其他子刊

147 0

[GetPortalCommentsPageByObjectIdResponse(id=2181467, encodeId=1748218146ef0, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jan 13 22:26:53 CST 2024, time=2024-01-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2134511, encodeId=5b3d2134511d4, content=Manuscript Under Consideration已经两个月了，请问是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3475520673, createdName=ms5000000882465531, createdTime=Mon May 15 15:30:16 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169851, encodeId=0b3321698518a, content=偏重的研究方向：信号通路;干细胞;GPCR 经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0838839473, createdName=ms2000001058758215, createdTime=Mon Nov 20 23:27:44 CST 2023, time=2023-11-20, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2141041, encodeId=5ca4214104108, content=Cell Discovery能比得上Mol Cell不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Tue Jun 06 10:38:36 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189973, encodeId=234021899e304, content=偏重的研究方向：免疫、单细胞测序 经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ce55107049, createdName=146080dfm79(暂无昵称), createdTime=Wed Feb 28 21:26:55 CST 2024, time=2024-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180511, encodeId=72062180511bb, content=请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d96302450, createdName=3783633_3040, createdTime=Wed Jan 10 15:23:06 CST 2024, time=2024-01-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170492, encodeId=db6921e0492ae, content=杂志口碑一般，有好的科研成果建议投其他子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8a8233627, createdName=ms8000001941475625, createdTime=Thu Nov 23 11:49:13 CST 2023, time=2023-11-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570206, encodeId=160c5e0206ee, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a32141202, createdName=05482, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576357, encodeId=3f5f5e6357e0, content=今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2311682109, createdName=加州理工的工人, createdTime=Sun Sep 15 19:42:00 CST 2019, time=2019-09-15, status=1, ipAttribution=)]

2022-05-20 dgdgdgygygyg

审稿速度:2.0 | 投稿命中率:5.0
经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？

198 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181467, encodeId=1748218146ef0, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jan 13 22:26:53 CST 2024, time=2024-01-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2134511, encodeId=5b3d2134511d4, content=Manuscript Under Consideration已经两个月了，请问是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3475520673, createdName=ms5000000882465531, createdTime=Mon May 15 15:30:16 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169851, encodeId=0b3321698518a, content=偏重的研究方向：信号通路;干细胞;GPCR 经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0838839473, createdName=ms2000001058758215, createdTime=Mon Nov 20 23:27:44 CST 2023, time=2023-11-20, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2141041, encodeId=5ca4214104108, content=Cell Discovery能比得上Mol Cell不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Tue Jun 06 10:38:36 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189973, encodeId=234021899e304, content=偏重的研究方向：免疫、单细胞测序 经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ce55107049, createdName=146080dfm79(暂无昵称), createdTime=Wed Feb 28 21:26:55 CST 2024, time=2024-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180511, encodeId=72062180511bb, content=请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d96302450, createdName=3783633_3040, createdTime=Wed Jan 10 15:23:06 CST 2024, time=2024-01-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170492, encodeId=db6921e0492ae, content=杂志口碑一般，有好的科研成果建议投其他子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8a8233627, createdName=ms8000001941475625, createdTime=Thu Nov 23 11:49:13 CST 2023, time=2023-11-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570206, encodeId=160c5e0206ee, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a32141202, createdName=05482, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576357, encodeId=3f5f5e6357e0, content=今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2311682109, createdName=加州理工的工人, createdTime=Sun Sep 15 19:42:00 CST 2019, time=2019-09-15, status=1, ipAttribution=)]

2019-04-29 05482

审稿速度:1.0 | 投稿命中率:50.0
经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept

357 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181467, encodeId=1748218146ef0, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：新冠的影响因子通货膨胀时代已经结束了，即时影响因子11分，未来分数应该会稳定在15-20分之间，国产中还是可以的，未来再想涨，只能学习sttt多收综述了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Sat Jan 13 22:26:53 CST 2024, time=2024-01-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2134511, encodeId=5b3d2134511d4, content=Manuscript Under Consideration已经两个月了，请问是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3475520673, createdName=ms5000000882465531, createdTime=Mon May 15 15:30:16 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169851, encodeId=0b3321698518a, content=偏重的研究方向：信号通路;干细胞;GPCR 经验分享：Cell research 放了一周后让转去这个杂志，不知道这是不是意味着大概率给送审啊？这个杂志今年影响因子会不会降啊，现在看时时影响因子才8分多也不知道准不准。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0838839473, createdName=ms2000001058758215, createdTime=Mon Nov 20 23:27:44 CST 2023, time=2023-11-20, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2141041, encodeId=5ca4214104108, content=Cell Discovery能比得上Mol Cell不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Tue Jun 06 10:38:36 CST 2023, time=2023-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189973, encodeId=234021899e304, content=偏重的研究方向：免疫、单细胞测序 经验分享：已经投稿21天了还是under consideration状态，这是还在editor那里嘛...不是说这个杂志稿件处理很快嘛...忐忑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ce55107049, createdName=146080dfm79(暂无昵称), createdTime=Wed Feb 28 21:26:55 CST 2024, time=2024-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180511, encodeId=72062180511bb, content=请问学界对这篇杂志的口碑到底如何？会不会影响申请基金？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d96302450, createdName=3783633_3040, createdTime=Wed Jan 10 15:23:06 CST 2024, time=2024-01-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2170492, encodeId=db6921e0492ae, content=杂志口碑一般，有好的科研成果建议投其他子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf8a8233627, createdName=ms8000001941475625, createdTime=Thu Nov 23 11:49:13 CST 2023, time=2023-11-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570206, encodeId=160c5e0206ee, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看好这个杂志，投了一篇，Cell research拒了建议转的这个，一审1个月，3个审稿人，意见正面，补少量实验1个月后修回，二审少数语言问题，一星期休回，然后accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a32141202, createdName=05482, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576357, encodeId=3f5f5e6357e0, content=今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2311682109, createdName=加州理工的工人, createdTime=Sun Sep 15 19:42:00 CST 2019, time=2019-09-15, status=1, ipAttribution=)]

2019-09-15 加州理工的工人

今年可能6到7分spanclassquote174978320190429发表br接收率约50审稿时间约1个月看好这个杂志投了一篇Cellresearch拒了建议转的这个一审1个月3个审稿人意见正面补少量实验1个月后修回二审少数语言问题一星期休回然后acceptspan

333 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务